Home › Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd
 

Keywords :   


Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd

2013-02-12 11:19:20| Biotech - Topix.net

The firm currently has a $41.00 target price on the stock. Zacks' analyst wrote, "Teva's fourth quarter earnings of $1.32 per American Depositary Share were a penny short of the Zacks Consensus Estimate and 17% below the year-ago earnings.

Tags: rating ltd industries neutral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Leslie Graphics
06.10Hurricane Leslie Forecast Discussion Number 16
06.10Hurricane Leslie Wind Speed Probabilities Number 16
06.10Hurricane Leslie Forecast Advisory Number 16
06.10Hurricane Leslie Public Advisory Number 16
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Kirk Graphics
06.10Tropical Storm Milton Graphics
More »